Cortical glucose metabolism in Parkinson's disease without dementia
- 30 June 1994
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 15 (3) , 329-335
- https://doi.org/10.1016/0197-4580(94)90028-0
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- COGNITIVE FUNCTION AND REGIONAL CEREBRAL BLOOD FLOW IN PARKINSON'S DISEASEBrain, 1992
- (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Mitochondrial Complex I Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- TIME COURSE OF EFFECTS OF UNILATERAL LESIONS OF THE NUCLEUS BASALIS OF MEYNERT ON GLUCOSE UTILIZATION BY THE CEREBRAL CORTEXBrain, 1989
- Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer typeJournal of Clinical and Experimental Neuropsychology, 1988
- Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTPLife Sciences, 1986
- THE EFFECTS OF L-DOPA ON REGIONAL CEREBRAL BLOOD FLOW AND OXYGEN METABOLISM IN PATIENTS WITH PARKINSON'S DISEASEBrain, 1985
- Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- ParkinsonismNeurology, 1967